Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Cancer, Metastatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02563054
What this trial is testing

Capecitabine (Xeloda) in Participants With Advanced or Metastatic Gastric Cancer

Who this might be right for
Gastric Cancer
Hoffmann-La Roche 316
Large-scale testing (Phase 3)Study completedNCT00099294
What this trial is testing

Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Threshold Pharmaceuticals 300
Testing effectiveness (Phase 2)Study completedNCT00205322
What this trial is testing

Oxaliplatin, 5-FU and Leucovorin in Combination With Oral Capecitabine for Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
University of Wisconsin, Madison 45
Testing effectiveness (Phase 2)Study completedNCT03698461
What this trial is testing

Treatment of Colorectal Liver Metastases With Immunotherapy and Bevacizumab

Who this might be right for
Colorectal NeoplasmsNeoplasm MetastasisColonic Neoplasms+1 more
Asan Medical Center 20
Large-scale testing (Phase 3)Study completedNCT00154102
What this trial is testing

Cetuximab Combined With Irinotecan in First-line Therapy for Metastatic Colorectal Cancer (CRYSTAL)

Who this might be right for
Epidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal Cancer
Merck KGaA, Darmstadt, Germany 1,221
Testing effectiveness (Phase 2)Study completedNCT00837031
What this trial is testing

Lenalidomide With Gemcitabine in Treatment of Untreated Advanced Carcinoma of the Pancreas

Who this might be right for
Metastatic Pancreatic Cancer
SCRI Development Innovations, LLC 72
Testing effectiveness (Phase 2)Study completedNCT00111761
What this trial is testing

Evaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Amgen 43
Early research (Phase 1)Study completedNCT02416466
What this trial is testing

CAR-T Hepatic Artery Infusions and Sir-Spheres for Liver Metastases

Who this might be right for
Liver Metastases
Roger Williams Medical Center 8
Testing effectiveness (Phase 2)Looking for participantsNCT07219459
What this trial is testing

Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure

Who this might be right for
Unresectable or Metastatic Hepatocellular CarcinomaChild-Pugh A Hepatocellular CarcinomaFailure of First-Line Treatment That Included an Approved Anti PD-(L)1 Compound
CatalYm GmbH 104
Not applicableUnknownNCT03956641
What this trial is testing

Evolution of the Physical Condition in Treated Cancer Patients

Who this might be right for
Non-small Cell Lung Cancer MetastaticBreast Cancer FemaleColon Cancer
Centre Paul Strauss 300
Large-scale testing (Phase 3)UnknownNCT04233151
What this trial is testing

QL1203 In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy and Safety

Who this might be right for
Metastatic Colorectal Cancer
Qilu Pharmaceutical Co., Ltd. 590
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Early research (Phase 1)Looking for participantsNCT06010862
What this trial is testing

Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors

Who this might be right for
Gastric CancerColon CancerPancreas Cancer+4 more
Chongqing Precision Biotech Co., Ltd 36
Not applicableLooking for participantsNCT06896162
What this trial is testing

PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival

Who this might be right for
Solid Tumor MalignanciesMetastatic CancerBreast Cancer+3 more
UNC Lineberger Comprehensive Cancer Center 500
Not applicableActive Not RecruitingNCT04157322
What this trial is testing

Plasma 5hmC Signatures as a Marker of Colorectal / Appendiceal Peritoneal Metastasis

Who this might be right for
Colorectal Cancer Stage IVColorectal Cancer MetastaticColorectal Cancer, Genetics of+1 more
University of Chicago 55
Post-approval studies (Phase 4)Ended earlyNCT00129870
What this trial is testing

CONCEPT: Comparison of Oxaliplatin vs Conventional Methods With Calcium/Magnesium in First-Line Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Sanofi 180
Testing effectiveness (Phase 2)UnknownNCT06085976
What this trial is testing

Efficacy and Safety of Octreotide in Laparoscopic Hepatectomy Surgery: Effect on Blood Loss, Need for Vasoactive Drugs, Transfusion Requirements.

Who this might be right for
Hepatic CarcinomaHepatic Metastasis
Clinica Universidad de Navarra, Universidad de Navarra 62
Testing effectiveness (Phase 2)Ended earlyNCT05311176
What this trial is testing

IMU-131 (HER-Vaxx) in Combination With Chemotherapy or Pembrolizumab in Patients With Metastatic HER2/Neu Over-Expressing Gastric Cancer (nextHERIZON)

Who this might be right for
Gastric CancerCancer of StomachGastric Adenocarcinoma+3 more
Imugene Limited 7
Not applicableNot Yet RecruitingNCT07826780
What this trial is testing

The STRONG Nutrition Support Study for People With Pancreatic Cancer

Who this might be right for
Pancreas Cancer, MetastaticPancreas Carcinoma
UNC Lineberger Comprehensive Cancer Center 80
Large-scale testing (Phase 3)Study completedNCT03520946
What this trial is testing

RAMucirumab in Combination Wth TAS102 vs. TAS102 Alone in Chemotherapy Refractory Metastatic Colorectal Cancer Patients

Who this might be right for
Colorectal Cancer
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 430
Next Page